Page last updated: 2024-09-04

sodium salicylate and Hepatocellular Carcinoma

sodium salicylate has been researched along with Hepatocellular Carcinoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fan, ST; Ho, DW; Poon, RT; To, J; Yang, ZF1
Mahmud, I; Miura, Y1
Cederbaum, AI; Wu, D1

Other Studies

3 other study(ies) available for sodium salicylate and Hepatocellular Carcinoma

ArticleYear
The potential role of hypoxia inducible factor 1alpha in tumor progression after hypoxia and chemotherapy in hepatocellular carcinoma.
    Cancer research, 2004, Aug-01, Volume: 64, Issue:15

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Caspases; Cell Hypoxia; Cisplatin; Combined Modality Therapy; Disease Progression; Hepatic Artery; HSP90 Heat-Shock Proteins; Hypoxia-Inducible Factor 1, alpha Subunit; Liver; Liver Neoplasms; Male; Necrosis; Rats; Rats, Inbred BUF; Sodium Salicylate; Survival Rate; Transcription Factors; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Up-Regulation; Vascular Endothelial Growth Factor A; Von Hippel-Lindau Tumor Suppressor Protein

2004
Effects of stimulators and inhibitors on arachidonic acid metabolism in hepatoma.
    Cellular and molecular biology, including cyto-enzymology, 1981, Volume: 27, Issue:2-3

    Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Butylated Hydroxytoluene; Carcinoma, Hepatocellular; Indomethacin; Liver Neoplasms; Prostaglandins; Rats; Sodium Salicylate; Thromboxane B2; Thromboxanes; Tryptophan

1981
Sodium salicylate increases CYP2E1 levels and enhances arachidonic acid toxicity in HepG2 cells and cultured rat hepatocytes.
    Molecular pharmacology, 2001, Volume: 59, Issue:4

    Topics: Allyl Compounds; Animals; Antioxidants; Apoptosis; Arachidonic Acid; Carcinoma, Hepatocellular; Cell Survival; Cells, Cultured; Chromans; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Synergism; Hepatocytes; Humans; Lipid Peroxidation; Male; Mixed Function Oxygenases; Protein Synthesis Inhibitors; Pyrazoles; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium Salicylate; Sulfides

2001